Page last updated: 2024-08-24

kynostatin 272 and warfarin

kynostatin 272 has been researched along with warfarin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ishino, M; Kiriyama, A; Kiso, Y; Nishiura, T; Ogita, I; Takada, K; Yamamoto, Y	1
Gold, D; Loftus, R	1

Other Studies

2 other study(ies) available for kynostatin 272 and warfarin

Article	Year
Binding characteristics of KNI-272 to plasma proteins, a new potent tripeptide HIV protease inhibitor. Biopharmaceutics & drug disposition, 1996, Volume: 17, Issue:9 Topics: Animals; Binding, Competitive; Blood Proteins; Chromatography, High Pressure Liquid; Diazepam; Digitoxin; Disopyramide; HIV Protease Inhibitors; Humans; Oligopeptides; Orosomucoid; Protein Binding; Rats; Serum Albumin; Warfarin	1996
Protease inhibitors: where are they now? GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 1995, Volume: 9, Issue:1 Topics: Animals; Blood Proteins; CD4 Lymphocyte Count; Clinical Trials as Topic; Drug Industry; Drug Resistance; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Isoquinolines; Oligopeptides; Protein Binding; Pyrones; Quinolines; Rats; Saquinavir; Technology, Pharmaceutical; Urea; Warfarin; Zidovudine	1995

Article

Year

Binding characteristics of KNI-272 to plasma proteins, a new potent tripeptide HIV protease inhibitor.

Biopharmaceutics & drug disposition, 1996, Volume: 17, Issue:9

Topics: Animals; Binding, Competitive; Blood Proteins; Chromatography, High Pressure Liquid; Diazepam; Digitoxin; Disopyramide; HIV Protease Inhibitors; Humans; Oligopeptides; Orosomucoid; Protein Binding; Rats; Serum Albumin; Warfarin

1996

Protease inhibitors: where are they now?

GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 1995, Volume: 9, Issue:1

Topics: Animals; Blood Proteins; CD4 Lymphocyte Count; Clinical Trials as Topic; Drug Industry; Drug Resistance; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Isoquinolines; Oligopeptides; Protein Binding; Pyrones; Quinolines; Rats; Saquinavir; Technology, Pharmaceutical; Urea; Warfarin; Zidovudine

1995